Human cholecystokinin type A receptor gene: Cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM)

Genomics

Volumn 42, Issue 2, 1997, Pages 331-335

  Inoue, Hiroshi ^a   Iannotti, Christopher A ^a   Welling, Cris M ^a   Veile, Rosalie ^a   Donis Keller, Helen ^a   Permutt, M Alan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CHROMOSOME 4; DATA BASE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MARKER GENE; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE METABOLISM; OBESITY; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALIA; CRICETINAE;

EID: 0031172165     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4749     Document Type: Article

References (19)

1. 1. Anonymous (1995). "Human Genetic Mapping Project, Data Release 9," Whitehead Institute/MIT Center for Genome Research. [December 1995].
2. 2. Chiu, K. C., Province, M. A., and Permutt, M. A. (1992). Glucokinase gene is genetic marker for NIDDM in American Blacks. Diabetes 41: 843-849.
3. 3. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. (1996). A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152-154.
4. 4. Funakoshi, A., Miyasaka, K., Jimi, A., Kawanai, T., Takata, Y., and Kono, A. (1994). Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats). Biochem. Biophys. Res. Commun. 199: 482-488.
5. 5. Funakoshi, A., Miyasaka, K., Shinozaki, H., Masuda, M., Kawanami, T., Takata, Y., and Kono, A. (1995). An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem. Biophys. Res. Commun. 210: 787-796.
6. 6. Huppi, K., Siwarski, D., Pisegna, J. R., and Wank, S. (1995). Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse. Genomics 25: 727-729.
7. 7. Jensen, R. T., Qian, J., Lin, J., Mantey, S.A., Pisegna, J. R., and Wank, S. A. (1994). Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors. In "Cholecystokinin" (Reeve, J. R. J., Eysselein, V., Solomon, T. E., and Go, V. L. W., Eds.), pp. 88-106, New York Academy of Sciences, New York.
8. 8. Jensen, R. T., Wank, S. A., Rowley, W. H., Sato, S., and Gardner, J. D. (1989). Interaction of CCK with pancreatic acinar cells. Trends Pharmacol. Sci. 10: 418-423.
9. 9. Kawano, K., Hirahashi, T., Mori, S., and Natori, T. (1994). OLETF (Otsuka Long-Evans Tokushima Fatty) rat: A new NIDDM rat strain. Diabetes Res. Clin. Pract. 24: S317-S320.
10. 10. Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., and Natori, T. (1992). Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima fatty (OLETF) strain. Diabetes 41: 1422-1428.
11. 11. Lichter, P., Cremer, T., Borden, J., Manuelidis, L., and Ward, D. C. (1988). Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80:224-234.
12. 12. Miller, L. J., Holicky, E. L., Ulrich, C. D., and Wieben, E. D. (1995). Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 109: 1375-1380.
13. 13. Nardone, G., Ferber, I. A., and Miller, L. J. (1995). The integrity of the cholecystokinin receptor gene in gallbladder disease and obesity. Hepatology 22: 1751-1753.
14. 14. Niederau, C., Luthen, R., and Heintges, T. (1994). Effects of CCK on pancreatic function and morphology. In Cholecystokinin (Reeve, J. R. J., Eysselein, V., Solomon, T. E., and Go, V. L. W., Eds.), pp. 180-198, New York Academy of Sciences, New York.
15. 15. Rigby, P. W., Dieckmann, M., Rhodes, C., and Berg, P. (1977). Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J. Mol. Biol. 113: 237-251.
16. 16. Smith, G. P., and Gibbs, J. (1994). Satiating effect of cholecystokinin. Ann. N.Y. Acad. Sci. 713: 236-241.
17. 17. Ulrich, C. D., Ferber, I., Holicky, E., Hadac, E., Buell, G., and Miller, L. J. (1993). Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor. Biochem. Biophys. Res. Commun. 193: 204-211.
18. 18. Verspohl, E. J., Ammon, H. P. T., Williams, J. A., and Goldfine, I. D. (1986). Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes 35: 38-43.
19. 19. Yunis, J. J. (1976). High resolution of human chromosomes. Science, 191: 1268-1270.